Amarin Corp Plcuk (AMRN) Change in Accured Expenses (2010 - 2026)

Amarin Corp Plcuk (AMRN) posted quarterly Change in Accured Expenses of -$14.8 million for Q1 2026, up 15.54% YoY from -$12.8 million in Q1 2025, and down 221.18% sequentially from $12.2 million in Q4 2025.

Amarin Corp Plcuk (AMRN) Change in Accured Expenses (2010 - 2026) Analysis & Trends

Amarin Corp Plcuk has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$14.8 million for Q1 2026.

  • In Q1 2026, Change in Accured Expenses rose 15.54% year-over-year to -$14.8 million; the TTM figure through Mar 2026 stood at $17.2 million (up 128.9% YoY), while the FY2025 annual figure was $14.5 million, up 118.85% from the prior year.
  • Change in Accured Expenses fell to -$14.8 million in Q1 2026, from $12.2 million in the prior quarter.
  • Over the last five years, Change in Accured Expenses for AMRN reached as high as $61.0 million in Q2 2022 and fell as low as -$69.7 million in Q1 2022.
  • The 5-year median for Change in Accured Expenses is -$14.8 million (2026), against an average of -$10.6 million.
  • Annual changes were most pronounced in 2022 — Change in Accured Expenses sank 1175.14% — and 2025, when it surged 176.85%.
  • A 5-year view of Change in Accured Expenses shows it stood at -$28.1 million in 2022, then soared by 73.09% to -$7.6 million in 2023, then tumbled by 186.16% to -$21.6 million in 2024, then soared by 156.59% to $12.2 million in 2025, then sank by 221.18% to -$14.8 million in 2026.
  • According to Business Quant data, Change in Accured Expenses over the past three periods registered -$14.8 million, $12.2 million, and -$3.7 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Accured Expenses (Qtr)
1 Eli Lilly 1,066.16 Bn 1,060.88 Bn 16.22 Bn -
2 Johnson & Johnson 611.69 Bn 589.64 Bn 15.96 Bn -629.00 Mn
3 AbbVie 444.34 Bn 434.99 Bn 10.78 Bn -1.59 Bn
4 Astrazeneca 284.94 Bn 277.05 Bn 12.61 Bn -
5 Merck 224.23 Bn 218.58 Bn 12.09 Bn -
6 Amgen 195.12 Bn 183.08 Bn 5.87 Bn -75.00 Mn
7 Gilead Sciences 156.45 Bn 148.73 Bn 5.52 Bn -702.00 Mn
8 Pfizer 136.01 Bn 123.24 Bn -1.21 Bn -
9 Novartis Ag 113.45 Bn 113.67 Bn - -
10 Amarin Corp Plcuk 5.17 Bn 5.00 Bn 17.77 Mn -14.82 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -14.82 Mn
Mar 31, 2026 -14.82 Mn
Dec 31, 2025 12.23 Mn
Dec 31, 2025 12.23 Mn
Sep 30, 2025 -3.71 Mn
Sep 30, 2025 -3.71 Mn
Jun 30, 2025 23.54 Mn
Jun 30, 2025 23.54 Mn
Mar 31, 2025 -17.54 Mn
Mar 31, 2025 -17.54 Mn
Dec 31, 2024 -21.61 Mn
Dec 31, 2024 -21.61 Mn
Sep 30, 2024 -28.99 Mn
Sep 30, 2024 -28.99 Mn
Jun 30, 2024 8.50 Mn
Jun 30, 2024 8.50 Mn
Mar 31, 2024 -34.90 Mn
Mar 31, 2024 -34.90 Mn
Dec 31, 2023 -7.55 Mn
Dec 31, 2023 -7.55 Mn